SelectQuote receives NYSE deficiency notice for sub-$1.00 stock price; 6-month cure period begins

SelectQuote, Inc.

NYSE notice on Oct 20, 2022: average closing price below $1.00 over 30 consecutive trading days.
Cure period is six months; compliance possible if closing price ≥$1.00 on last trading day of any calendar month and 30-day average ≥$1.00.
Company will notify NYSE of intent to cure; shares continue trading during cure period subject to other standards.
If stockholder approval is needed for cure, price must promptly exceed $1.00 and remain above for 30 trading days.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.